Abstract
Purpose
Bariatric surgery candidates are frequently treated with antidepressants. Several of these drugs have been associated with weight gain and could potentially interfere with weight loss after bariatric surgery. This cohort study aimed to investigate the short-term effects of antidepressants on weight loss during the first 24 months after a Roux-en-Y gastric bypass.
Methods
Patients with a fully documented antidepressant treatment status for at least 12 months were retrospectively included. Weight loss was expressed as the percentage excess BMI loss (%EBMIL) or percentage total weight loss (%TWL). A mixed linear effects model was used to determine the impact of continued and discontinued treatment with antidepressants on weight loss.
Results
A total of 751 patients were included in this study. At 24 months, patients had lost 77.38 ± 30.10 %EBMIL (30.63 ± 13.12 %TWL). In patients treated with antidepressants (n = 125), the %EBMIL and %TWL was reduced with − 2.81% (p = 0.025) and − 1.36% (p = 0.002) respectively, and with − 5.52 %EBMIL (p < 0.001; − 1.05 %TWL, p = 0.012) after multivariate adjustment. Serotonin-norepinephrine reuptake inhibitors (− 12.47 %EBMIL, p < 0.001) and tricyclic antidepressants (− 11.01 %EBMIL, p = 0.042) were predominantly responsible for worse outcomes. Beyond 24 months, at 36 months (− 4.83%, p < 0.001) and 48 months (− 3.54%, p = 0.006), the %EBMIL was still reduced. No significant effects of antidepressants on metabolic outcomes after surgery were observed.
Conclusions
Treatment with antidepressants was associated with reduced weight loss after gastric bypass surgery, but only if treatment was continued for at least 1 year postoperatively. Mainly tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors were responsible for this reduction in weight loss.
Similar content being viewed by others
Abbreviations
- RYGB:
-
Roux-en-Y gastric bypass
- BMI:
-
Body mass index (weight/length2)
- %EBMIL:
-
Percentage excess BMI loss
- %TWL:
-
Percentage total weight loss
- SSRI:
-
Selective serotonin reuptake inhibitor
- SNRI:
-
Serotonin-norepinephrine reuptake inhibitor
- TCA:
-
Tricyclic antidepressant
- NDRI:
-
Norepinephrine and dopamine reuptake inhibitor
- 95%CI:
-
95% confidence interval
- SD:
-
Standard deviation
- HDL:
-
High-density lipoprotein
References
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14):1724–1737
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(3):248–256.e245
Still CD, Wood GC, Chu X, Manney C, Strodel W, Petrick A, Gabrielsen J, Mirshahi T, Argyropoulos G, Seiler J, Yung M, Benotti P, Gerhard GS (2014) Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 22(3):888–894
Wimmelmann CL, Dela F, Mortensen EL (2014) Psychological predictors of weight loss after bariatric surgery: a review of the recent research. Obes Res Clin Pract 8(4):e299–e313
Kalarchian MA, King WC, Devlin MJ, Marcus MD, Garcia L, Chen JY, Yanovski SZ, Mitchell JE (2016) Psychiatric disorders and weight change in a prospective study of bariatric surgery patients: a 3-year follow-up. Psychosom Med 78(3):373–381
Rutledge T, Groesz LM, Savu M (2011) Psychiatric factors and weight loss patterns following gastric bypass surgery in a veteran population. Obes Surg 21(1):29–35
Rydén A, Torgerson JS (2006) The Swedish Obese Subjects Study—what has been accomplished to date? Surg Obes Relat Dis 2(5):549–560
Dawes AJ, Maggard-Gibbons M, Maher AR, Booth MJ, Miake-Lye I, Beroes JM, Shekelle PG (2016) Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA 315(2):150–163
Mitchell JE, King WC, Chen JY, Devlin MJ, Flum D, Garcia L, Inabet W, Pender JR, Kalarchian MA, Khandelwal S, Marcus MD, Schrope B, Strain G, Wolfe B, Yanovski S (2014) Course of depressive symptoms and treatment in the longitudinal assessment of bariatric surgery (LABS-2) study. Obesity (Silver Spring) 22(8):1799–1806
Gafoor R, Booth HP, Gulliford MC (2018) Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ 361:k1951
Serretti A, Mandelli L (2010) Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 71(10):1259–1272
Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmächer T (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37(3):193–220
Uguz F, Sahingoz M, Gungor B, Aksoy F, Askin R (2015) Weight gain and associated factors in patients using newer antidepressant drugs. Gen Hosp Psychiatry 37(1):46–48
Love RJ, Love AS, Bower S, Carlos Poston WS (2008) Impact of antidepressant use on gastric bypass surgery patients’ weight loss and health-related quality-of-life outcomes. Psychosomatics 49(6):478–486
Malone M, Alger-Mayer SA, Polimeni JM (2011) Antidepressant drug therapy does not affect weight loss one year after gastric bypass surgery. Obes Surg 21(11):1721–1723
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391(10128):1357–1366
Cunningham JL, Merrell CC, Sarr M, Somers KJ, McAlpine D, Reese M, Stevens SR, Clark MM (2012) Investigation of antidepressant medication usage after bariatric surgery. Obes Surg 22(4):530–535
Wysokinski AKI (2014) Mechanisms of increased appetite and weight gain induced by psychotropic medications. J. Adv. Clin. Pharmacol. 1:12–33
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA (2016) The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 85(5):270–288
de Jonge L, Petrykiv S, Fennema J, Arts M (2017) The effects of bariatric surgery on pharmacokinetics of antidepressants: a systematic review. Eur Psychiatry 41:S232–S233
American Psychiatric Association (APA), Practice guideline for the treatment of patients with major depressive disorder - third edition (2010)
National Institute for Health and Care Excellence (NICE), Depression in adults: recognition and management. (2009 (updated 2018))
Ryder JR, Gross AC, Fox CK, Kaizer AM, Rudser KD, Jenkins TM, Ratcliff MB, Kelly AS, Kirk S, Siegel RM, Inge TH (2018) Factors associated with long-term weight loss maintenance following bariatric surgery in adolescents with severe obesity. Int J Obes 42(1):102–107
Wood G, Benotti PN, Lee CJ et al (2016) Evaluation of the association between preoperative clinical factors and long-term weight loss after Roux-en-Y gastric bypass. JAMA Surg 151(11):1056–1062
Acknowledgements
The authors thank Maud De Venter for her assistance in the preoperative psychological assessment.
Author information
Authors and Affiliations
Contributions
Plaeke P: study conception and design, acquisition of data, analysis and interpretation of data, drafting of manuscript, critical revision of manuscript. Van Den Eede F: study conception and design, interpretation of data, drafting of manuscript, critical revision of manuscript. Gys B: critical revision of manuscript. Beunis A: critical revision of manuscript. Ruppert M: critical revision of manuscript. De Man J: critical revision of manuscript. De Winter B: analysis and interpretation of data, drafting of manuscript, critical revision of manuscript. Hubens G: study conception and design, interpretation of data, drafting of manuscript, critical revision of manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Retrospective data collection was approved by the ethical committee of the Antwerp University Hospital (File number 15/48/513).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Plaeke, P., Van Den Eede, F., Gys, B. et al. Postoperative continuation of antidepressant therapy is associated with reduced short-term weight loss following Roux-en-Y gastric bypass surgery. Langenbecks Arch Surg 404, 621–631 (2019). https://doi.org/10.1007/s00423-019-01784-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-019-01784-z